GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share (TYRA)

Symbol: TYRA on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$17,296,136	657,756	+60,302	+10%	$26.30	Q4 2025
30 Sep 2025	0%	+0%	$8,359,761	597,454	+30,328	+5.3%	$13.99	Q3 2025
30 Jun 2025	0%	+0%	$5,428,267	567,126	+50,836	+9.8%	$9.57	Q2 2025
31 Mar 2025	0%	-0%	$4,802,525	516,290	-1,288		$9.30	Q1 2025
31 Dec 2024	0%	-0%	$7,195,866	517,578	-5,612	-1.1%	$13.90	Q4 2024
30 Sep 2024	0%	+0%	$12,302,284	523,190	+516	+0.1%	$23.51	Q3 2024
30 Jun 2024	0%	+0%	$8,359,039	522,674	+105,866	+25%	$15.99	Q2 2024
31 Mar 2024	0%	+0%	$6,837,116	416,808	+83,339	+25%	$16.40	Q1 2024
31 Dec 2023	0%	+0%	$4,619,036	333,469	+18,991	+6%	$13.85	Q4 2023
30 Sep 2023	0%	+0%	$4,330,899	314,478	+24,480	+8.4%	$13.77	Q3 2023
30 Jun 2023	0%	+0%	$4,938,665	289,998	+3,894	+1.4%	$17.03	Q2 2023
31 Mar 2023	0%	+0%	$4,597,691	286,104	+32,412	+13%	$16.07	Q1 2023
31 Dec 2022	0%	+0%	$1,928,000	253,692	+6,242	+2.5%	$7.60	Q4 2022
30 Sep 2022	0%	+0%	$2,175,000	247,450	+22,039	+9.8%	$8.79	Q3 2022
30 Jun 2022	0%	+0%	$1,611,000	225,411	+14,862	+7.1%	$7.15	Q2 2022
31 Mar 2022	0%	+0%	$2,252,000	210,549	+4,168	+2%	$10.70	Q1 2022
31 Dec 2021	0%	+0%	$2,903,000	206,381	+206,381	NEW	$14.07	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.